Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis

Completed · Not applicable

Conditions studied: Cystic Fibrosis

In brief

This study is a single center, randomized pilot study to evaluate the clinical effectiveness of nasal high flow 20LPM humidification therapy in subjects with Cystic Fibrosis.

Key facts

Study ID

NCT02129803

Run by

Virginia Commonwealth University

People needed

24

Starts

2015-05-01

Expected to finish

2019-05-29

Last updated by the study team

2021-01-06

Who can join

Age: 10 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed diagnosis of CF
• Hospital admission for acute pulmonary exacerbation of CF (using Fuchs criteria 4/10)
• 10 years of age and older
• Subject is able to comply with the procedures scheduled in the protocol
• Signed informed consent form

You may not qualify if…

• Receipt of any aerosolized experimental or investigational drugs within 1 month of enrollment
• Subject had ear, nose, and throat (ENT) surgery, nasal bleeding, or nasal polyps within 6 months prior to study
• Subject is unlikely to comply with the procedures scheduled in the protocol
• Inability to give informed consent
• Subject requires supplemental oxygen
• History of obstructive sleep apnea
• History of pressure headaches requiring therapy within one month of enrollment
• Any other medical or psychological condition in which the study doctor(s) believe(s) would inhibit the individual from being an appropriate study subject.

Where it is running

• Children's Hospital of Richmond at VCU — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.